Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
about
Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties.Evaluation of novel large cut-off ultrafiltration membranes for adenovirus serotype 5 (Ad5) concentration.The use of recombinant adeno-associated virus for skeletal gene therapy.Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency.Relation of structure to performance characteristics of monolithic and perfusive stationary phases.Downstream processing of cell culture-derived virus particles.A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.Adeno-Associated Virus Gene Therapy for Liver Disease.Standard free droplet digital polymerase chain reaction as a new tool for the quality control of high-capacity adenoviral vectors in small-scale preparations.Production and titering of recombinant adeno-associated viral vectors.Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography.Human papillomavirus type 58 L1 virus-like particles purified by two-step chromatography elicit high levels of long-lasting neutralizing antibodies.Development of a platform process for adenovirus purification that removes human SET and nucleolin and provides high purity vector for gene delivery.Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C.Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver.
P2860
Q33555259-F62C498D-74D3-4975-B91A-45D25DA6D489Q35535220-81DEB52A-3F31-4C14-8F01-785ACCEE8DF2Q36729692-C336C3A9-D466-4A57-8F5E-7FE4C5DEF7F2Q37313583-185B45B3-B690-4B57-9553-1DD8F687C34EQ37364353-53A46AAB-24FF-4CA4-AD82-E0EAE6CAAF10Q37944322-8C7CC3CD-B827-49B7-AED4-F39B3684470DQ38341551-BA24BC0A-B1F9-486F-AED8-B180307EA53AQ38789554-B2FC6599-5DAF-407A-813E-49924DDD65B2Q38914385-4B3B658D-944C-4CCF-8DAA-5021F8412524Q42575413-4A3D271E-F59F-42C9-A8DF-D819AB481199Q44197060-D6B3B5C2-59F7-43CF-88FF-9E16B34F68C4Q45354893-EC094101-F198-46D7-A14C-1A5E2BDE4F25Q45882344-77B8F1F9-8549-4629-AAFB-ABDE0709669AQ47100523-38983AF5-637D-46E3-850D-51005BAE4B16Q54241222-9D7DCB19-C3E4-49DD-966D-1960B007F1F2
P2860
Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Chromatographic purification o ...... ors: methods and implications.
@ast
Chromatographic purification o ...... ors: methods and implications.
@en
type
label
Chromatographic purification o ...... ors: methods and implications.
@ast
Chromatographic purification o ...... ors: methods and implications.
@en
prefLabel
Chromatographic purification o ...... ors: methods and implications.
@ast
Chromatographic purification o ...... ors: methods and implications.
@en
P2860
P356
P1433
P1476
Chromatographic purification o ...... ors: methods and implications.
@en
P2093
P2860
P2888
P356
10.1038/SJ.GT.3302611
P478
12 Suppl 1
P577
2005-10-01T00:00:00Z